| 1 |
34868360 | mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab. | 2022 Jan |
2 |
| 2 |
34991339 | Collagen fibrous scaffolds for sustained delivery of growth factors for meniscal tissue engineering. | 2022 Jan |
1 |
| 3 |
35485302 | Duo Cadherin-Functionalized Microparticles Synergistically Induce Chondrogenesis and Cartilage Repair of Stem Cell Aggregates. | 2022 Apr 29 |
2 |
| 4 |
33463282 | Engineering a Self-Assembling Leucine Zipper Hydrogel System with Function-Specific Motifs for Tissue Regeneration. | 2020 May 11 |
4 |
| 5 |
31536840 | An injectable heparin-conjugated hyaluronan scaffold for local delivery of transforming growth factor β1 promotes successful chondrogenesis. | 2019 Nov |
4 |
| 6 |
28457186 | Heparin Augmentation Enhances Bioactive Properties of Acellular Extracellular Matrix Scaffold. | 2018 Jan |
1 |
| 7 |
29139224 | A polyelectrolyte multilayer platform for investigating growth factor delivery modes in human liver cultures. | 2018 Apr |
2 |
| 8 |
29760942 | Induction of chondrogenesis of human placenta-derived mesenchymal stem cells via heparin-grafted human fibroblast derived matrix. | 2018 |
1 |
| 9 |
28468283 | Heparin, Heparan Sulphate and the TGF-β Cytokine Superfamily. | 2017 Apr 29 |
1 |
| 10 |
29806444 | [Research progress in osteogenesis and osteogenic mechanism of heparan sulfate]. | 2017 Aug 15 |
1 |
| 11 |
26990913 | Cell number and chondrogenesis in human mesenchymal stem cell aggregates is affected by the sulfation level of heparin used as a cell coating. | 2016 Jul |
8 |
| 12 |
25682155 | Enhanced survival and engraftment of transplanted stem cells using growth factor sequestering hydrogels. | 2015 Apr |
2 |
| 13 |
25931306 | Molecular weight and concentration of heparin in hyaluronic acid-based matrices modulates growth factor retention kinetics and stem cell fate. | 2015 Jul 10 |
3 |
| 14 |
26156753 | Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression. | 2015 Sep 10 |
2 |
| 15 |
26219861 | TGFβ functionalized starPEG-heparin hydrogels modulate human dermal fibroblast growth and differentiation. | 2015 Oct |
2 |
| 16 |
26306634 | Structural determinants of heparin-transforming growth factor-β1 interactions and their effects on signaling. | 2015 Dec |
5 |
| 17 |
25126416 | Characterization of a multilayer heparin coating for biomolecule presentation to human mesenchymal stem cell spheroids. | 2014 May 1 |
1 |
| 18 |
23571852 | Perturbation of the heparin/heparin-sulfate interactome of human breast cancer cells modulates pro-tumourigenic effects associated with PI3K/Akt and MAPK/ERK signalling. | 2013 Jun |
3 |
| 19 |
24247664 | Heparin inhibits activation of latent transforming growth factor-β1. | 2013 |
3 |
| 20 |
21669031 | In situ cardiomyogenic differentiation of implanted bone marrow mononuclear cells by local delivery of transforming growth factor-β1. | 2012 |
1 |
| 21 |
22406166 | Measurement of human latent Transforming Growth Factor-β1 using a latency associated protein-reactive ELISA. | 2012 May 31 |
1 |
| 22 |
22522458 | Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis. | 2012 May |
2 |
| 23 |
23207953 | Low molecular weight heparin inhibits circulating fibrocytes differentiation by modulating neuronal nitric oxide synthase and TGF-β1/Smad pathway. | 2012 |
1 |
| 24 |
20955806 | Effects of TGF-β1 on alternative splicing of Superficial Zone Protein in articular cartilage cultures. | 2011 Jan |
2 |
| 25 |
20599451 | Preparation of TGF-β1-conjugated biodegradable pluronic F127 hydrogel and its application with adipose-derived stem cells. | 2010 Oct 1 |
1 |
| 26 |
19520426 | In situ chondrogenic differentiation of human adipose tissue-derived stem cells in a TGF-beta1 loaded fibrin-poly(lactide-caprolactone) nanoparticulate complex. | 2009 Sep |
4 |
| 27 |
19748283 | Bioactive TGF-beta levels can be preserved in plasma samples collected into heparin but not EDTA. | 2009 Dec |
2 |
| 28 |
18443513 | Effect of heparin on production of transforming growth factor (TGF)-beta1 and TGF-beta1 mRNA expression by human normal skin and hyperplastic scar fibroblasts. | 2008 Mar |
11 |
| 29 |
17389624 | Enoxaparin but not unfractionated heparin causes a dose-dependent increase in plasma TGF-beta 1 during haemodialysis: a cross-over study. | 2007 Jun |
1 |
| 30 |
17969246 | Effect of heparin on production of basic fibroblast growth factor and transforming growth factor-beta1 by human normal skin and hyperplastic scar fibroblasts. | 2007 Sep-Oct |
5 |
| 31 |
16055320 | Activation of valvular interstitial cells is mediated by transforming growth factor-beta1 interactions with matrix molecules. | 2005 Sep |
4 |
| 32 |
15149336 | Role of mast cells in the development of renal fibrosis: use of mast cell-deficient rats. | 2004 Jun |
1 |
| 33 |
15648575 | Effect of a dextran derivative associated with TGF-beta1 or FGF-2 on dermal fibroblast behaviour in dermal equivalents. | 2004 |
2 |
| 34 |
12640331 | Heparin stimulates production of bFGF and TGF-beta 1 by human normal, keloid, and fetal dermal fibroblasts. | 2003 Mar |
5 |
| 35 |
12768067 | Heparin reduces glomerular infiltration and TGF-beta protein expression by macrophages in puromycin glomerulosclerosis. | 2003 Mar-Apr |
5 |
| 36 |
11436205 | Quantitation of TGF-beta1 mRNA in porcine mesangial cells by comparative kinetic RT/PCR: comparison with ribonuclease protection assay and in situ hybridization. | 2001 |
1 |
| 37 |
11532088 | Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation. | 2001 Sep |
4 |
| 38 |
11798537 | [The potential role of growth factor in the airway wall remodeling of a chronic obstructive pulmonary disease rat model and the effects of drugs on them]. | 2000 Nov |
1 |
| 39 |
9662260 | The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7). | 1998 Jul |
1 |
| 40 |
9218427 | The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific. | 1997 Jul 18 |
2 |
| 41 |
7511146 | Protection of transforming growth factor-beta 1 activity by heparin and fucoidan. | 1994 Apr |
7 |
| 42 |
7514054 | A study of the effects of human blood derivatives and individual growth factors on [3H]thymidine uptake in bovine retinal pericytes and endothelial cells. | 1993 |
2 |
| 43 |
1639873 | Transforming growth factor-beta 1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1. | 1992 Aug |
15 |
| 44 |
1704799 | Reaction of alpha 2-macroglobulin with plasmin increases binding of transforming growth factors-beta 1 and beta 2. | 1991 Jan 31 |
3 |
| 45 |
1846019 | Heparin and hormonal regulation of mRNA synthesis and abundance of autocrine growth factors: relevance to clonal growth of tumors. | 1991 Jan |
3 |
| 46 |
2473082 | Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex. | 1989 Jul |
14 |
| 47 |
3475277 | Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. | 1987 Jul |
3 |